IM Cannabis (NASDAQ:IMCC – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating Read More
October 24, 2025
Organigram Global Inc. (NASDAQ:OGI – Free Report) – Equities researchers at Atb Cap Markets cut their FY2025 earnings estimates for shares Read More
President Trump is reported to be open to reclassifying marijuana as a less dangerous Schedule III drug, which would benefit Read More
Are cannabis users worse transplant recipients, or is the denial of transplant for cannabis use just a type of bias? Read More
Expion360, Trinity Biotech, OneMedNet, TPI Composites, Ondas, Tilray Brands, and Biomerica are the seven Penny stocks to watch today, according Read More
Risk and Volatility Insynergy Products has a beta of 0.2, indicating that its share price is 80% less volatile than the S&Read More
Organigram Global (NASDAQ:OGI – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” Read More
Tilray says it requested an extension to regain compliance with minimum listing requirements of the Nasdaq Exchange. Here’s why Read More
President Donald Trump may reclassify marijuana as less dangerous after cannabis interests poured money into his campaign. President Donald Trump Read More
Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Read More